In addition, overexpression of ITGB4 was more frequently observed in ccRCC with nodal metastases as well as in tumors of subtype B (Fig. 1g, h) that are associated with higher recurrence rate and mortality rate [32]. This evidence concerns the gene ITGB4 and nonpapillary renal cell carcinoma.